Jpmorgan Chase & Co »

Fortress Biotech shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Fortress Biotech (FBIO) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Fortress Biotech

Tip: Access up to 7 years of quarterly data

All positions including Fortress Biotech held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fortress Biotech by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3k 672 2.00
2023-12-31 $3.9k 1.3k 3.01

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Fortress Biotech

Rosalind Advisors
Vanguard Group
Acadian Asset Management
Nantahala Capital Management
Shikiar Asset Management
Pvg Asset Management
Geode Capital Management
GSA Capital Partners
CI Private Wealth
Susquehanna International
Envestnet Asset Management
BlackRock
Commonwealth Equity Services
Wealth Enhancement Advisory Services
Northern Trust

View all funds holding Fortress Biotech